March 29, 2017
Good News for Rich Eczema Sufferers!

From the New York Times:

A country whose electorate allows this kind of shit to happen is a country too stupid to live:

The Food and Drug Administration on Tuesday approved a drug to treat people with a serious form of eczema, a potential breakthrough for people who have suffered for years without relief. But it will not come cheap.

The drug, to be called Dupixent, will carry a list price of $37,000 a year, a hefty price tag for patients who are increasingly being asked to pay a larger share of the drugs they take. Still, its price is a bit lower than many other commonly used biologic drugs, such as Humira and Enbrel, that treat other skin diseases…

The best-selling products Humira and Enbrel, which treat the skin disease psoriasis and other conditions, carry annual list prices of about $50,000.



Posted by Jerome Doolittle at March 29, 2017 03:33 PM
Email this entry to:

Your email address:

Message (optional):


Heh heh heh! We in the drug industry have you exactly where we want you. Pay up — or scratch yourself until you bleed to death.

Excuse me now, while I go pray to our industry's patron saint, Martin Shkreli.

Yours very crankily,
The New York Crank

Posted by: The New York Crank on April 3, 2017 11:41 PM
Post a comment

Email Address:



Remember info?